Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/31/2026 | Q1 | $509K | -- | -- | -- | -- |
| 03/12/2026 | Q4 | $1.5M | -- | -- | -$0.22 | -- |
| 11/04/2025 | Q3 | $994.8K | $1.2M | -$0.20 | -$0.22 | $0.02 |
| 08/05/2025 | Q2 | $2.5M | $1.6M | -$0.25 | -$0.20 | -$0.05 |
| 04/30/2025 | Q1 | $369.1K | $1.1M | -$0.21 | -$0.24 | $0.03 |
| 03/13/2025 | Q4 | $820.9K | $1.3M | -$0.18 | -$0.21 | $0.03 |
| 10/24/2024 | Q3 | $8.4M | $29.4M | $0.06 | -$0.22 | $0.29 |
| 07/17/2024 | Q2 | $75.9M | $759.5K | -$0.25 | $0.27 | -$0.52 |
| 04/25/2024 | Q1 | $5.8M | -- | -$0.21 | -$0.13 | -$0.08 |
| 02/06/2024 | Q4 | $11.4M | $16.7M | -$0.06 | -$0.18 | $0.12 |
| 11/03/2023 | Q3 | -- | -- | -$0.20 | -- | -- |
| 08/04/2023 | Q2 | -- | -- | -$0.22 | -- | -- |
| 04/28/2023 | Q1 | -- | -- | -$0.23 | -- | -- |
| 03/16/2023 | Q4 | -- | $1K | -$0.23 | -- | -- |
| 10/28/2022 | Q3 | -- | $4.1M | -$0.17 | -- | -- |
| 07/28/2022 | Q2 | -- | -- | -$0.24 | -- | -- |
| 04/28/2022 | Q1 | -- | -- | -$0.24 | -- | -- |
| 03/22/2022 | Q4 | -- | -- | -$0.28 | -- | -- |
| 11/08/2021 | Q3 | -- | -- | -$0.24 | -- | -- |
| 08/04/2021 | Q2 | -- | -- | -$0.29 | -- | -- |
| 04/28/2021 | Q1 | -- | -- | -$0.26 | -- | -- |
| 03/30/2021 | Q4 | -- | $1M | -$0.30 | -- | -- |
| 11/13/2020 | Q3 | -- | $1.2M | -$0.29 | -- | -- |
| 08/05/2020 | Q2 | -- | $1.1M | -$0.23 | -- | -- |
| 05/04/2020 | Q1 | -- | $12.7M | -$0.11 | -- | -- |
| 03/30/2020 | Q4 | -- | $868.8K | -$0.27 | -- | -- |
| 11/13/2019 | Q3 | -- | $33.7M | $0.26 | -- | -- |
| 08/14/2019 | Q2 | -- | $1.5M | -$0.24 | -- | -- |
| 05/15/2019 | Q1 | -- | $75.3M | $0.91 | -- | -- |
| 03/21/2019 | Q4 | -- | $1.4M | -$0.22 | -- | -- |
| 11/13/2018 | Q3 | -- | $2.3M | -$0.21 | -- | -- |
| 08/08/2018 | Q2 | -- | $2.1M | -$0.19 | -- | -- |
| 05/02/2018 | Q1 | -- | $1.5M | -$0.21 | -- | -- |
| 03/20/2018 | Q4 | -- | $16.6M | $0.07 | -- | -- |
| 11/13/2017 | Q3 | -- | $1.1M | -$0.16 | -- | -- |
| 08/09/2017 | Q2 | -- | $765.2K | -$0.22 | -- | -- |
| 03/31/2017 | Q1 | -- | $2M | -$0.17 | -- | -- |
| 03/17/2017 | Q4 | -- | $1.4M | -$0.08 | -- | -- |
| 09/30/2016 | Q3 | -- | $1.4M | -$0.18 | -- | -- |
| 06/30/2016 | Q2 | -- | $20.6M | $0.27 | -- | -- |
| 03/31/2016 | Q1 | -- | $490K | -$0.11 | -- | -- |
AC Immune SA reported $1.2M worth of top line sales in its most recent quarter.
AC Immune SA announced earnings per share of -$0.20 which represents a beat of analyst forecast a -$0.22 per share.
AC Immune SA reported -- that represents -- per share over the last quarter.
AC Immune SA's earnings are forecast to decrease from -$0.58 per share to -$0.90 per share next year representing a decrease of -28.24%.
AC Immune SA's next earnings date is March 12, 2026.
Signup to receive the latest stock alerts
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Though certainly less well-known than the huge tech businesses that…
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Market Cap: $4.6T
P/E Ratio: 65x
Market Cap: $3.8T
P/E Ratio: 35x
Market Cap: $3.8T
P/E Ratio: 29x
Teradata Corp. [TDC] is down 11.64% over the past day.
Diodes, Inc. [DIOD] is down 7.63% over the past day.
Vertiv Holdings Co. [VRT] is down 4.79% over the past day.